glp-1 heart attack The Cardiovascular Biology of Glucagon-like Peptide-1 Cardiovascular Effects of Glucagon-Like Peptide-1

Thyroid Function and Risk of Type 2 Diabetes: A Population-Based Prospective Cohort Study

Clinical oversight is provided by pharmacist independent prescribers rather than doctors

doi: 10.1038/sj.ijo.0802206 100 KastinA

While more research is needed to confirm these findings, this growing body of evidence indicates that GLP-1 pathways may have protective effects in the digestive tract, beyond their traditional use in metabolic care

[PubMed] [Google Scholar] 85.Han V.K., Hynes M.A., Jin C., Towle A.C., Lauder J.M., Lund P.K

The FDA approval of Wegovy for certain adults with MASH and moderate-to-advanced fibrosis made this connection even more important for patients to understand